Molecular Detection of Circulating Tumor Cells in Colorectal Cancer Patients: From Laboratory Investigation to Clinical Implication

Fooyin Journal of Health Sciences

Volumn 1, Issue 1, 2009, Pages 2-10

  Wang, Hwei Ming ^a   Lin, Shiu Ru ^b,c   Uen, Yih Huei ^d,e,f   Wang, Jaw Yuan ^g,h  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d Chi Mei Medical Centre   (Taiwan)

^e SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

circulating tumor cell; colorectal cancer; membrane array; molecular detection

Indexed keywords

CETUXIMAB; DNA; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MESSENGER RNA; MOLECULAR MARKER; OXALIPLATIN;

CANCER MORTALITY; CANCER PATIENT; CARCINOGENESIS; CELL SELECTION; COLORECTAL CANCER; HUMAN; IMMUNOCYTOCHEMISTRY; MICROMETASTASIS; NUCLEIC ACID ANALYSIS; OVERALL SURVIVAL; PREDICTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR CELL;

EID: 71649113400     PISSN: 18778607     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1877-8607(09)60002-3     Document Type: Review

References (88)

1. Boyle P., and Leon M.E. Epidemiology of colorectal cancer. Br Med Bull 64 (2002) 1-25
2. Department of Health, Executive Yuan, Taiwan, R.O.C. Available at http://www.doh.gov.tw/statistic/index.htm [Date accessed: January 2009]
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
4. Wiggers T., Arends J.W., Schutte B., et al. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 61 (1988) 386-395
5. Vernava A.M., Longo W.E., Virgo K.S., et al. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 37 (1994) 573-583
6. Soreide O., and Norstein J. Local recurrence after operative treatment of rectal carcinoma: a strategy for change. J Am Coll Surg 184 (1997) 84-92
7. Goldberg R.M., Fleming T.R., Tangen C.M., et al. Surgery for recurrent colon cancer: strategies for identifying respectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129 (1998) 27-35
8. Rosen M., Chan L., Beart Jr. R.W., et al. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 41 (1998) 1116-1126
9. Sung J.J., Lau J.Y., Young G.P., et al. Asia Pacific Working Group on Colorectal Cancer. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57 (2008) 1166-1176
10. Liotta L.A., and Stetler-Stevenson W.G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51 Suppl 18 (1991) 5054-5059
11. Duffy M.J., McGowan P.M., and Gallagher W.M. Cancer invasion and metastasis: changing views. J Pathol 214 (2008) 283-293
12. Liotta L.A., Saidel M.G., and Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36 (1976) 889-894
13. Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br J Cancer 48 (1983) 665-673
14. Lindemann F., Schlimok G., Dirschedl P., et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340 (1992) 685-689
15. Soeth E., Vogel I., Röder C., et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57 (1997) 3106-3110
16. Martin V.M., Siewert C., Scharl A., et al. Immunomagnetic en richment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 26 (1998) 252-264
17. Molnar B., Ladanyi A., Tanko L., et al. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 7 (2001) 4080-4085
18. Racila E., Euhus D., Weiss A.J., et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95 (1998) 4589-4594
19. Cohen S.J., Alpaugh R.K., Gross S., et al. Isolation and characterization of circulating tumor cells in patients with meta-static colorectal cancer. Clin Colorectal Cancer 6 (2006) 125-132
20. Pantel K., Felber E., and Schlimok G. Detection and characterization of residual disease in breast cancer. J Hematother 3 (1994) 315-322
21. Pantel K., Schlimok G., Braun S., et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85 (1993) 1419-1424
22. Mehes G., Luegmayr A., Ambros I.M., et al. Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow. Clin Cancer Res 7 (2001) 1969-1975
23. Kraeft S.K., Ladanyi A., Galiger K., et al. Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system. Clin Cancer Res 10 (2004) 3020-3028
24. Cristofanilli M., Budd G.T., Ellis M.J., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351 (2004) 781-791
25. Pantel K., and Alix-Panabieres C. The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 4 (2007) 62-63
26. Alix-Panabieres C., Vendrell J.P., Pelle O., et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 53 (2007) 537-539
27. Braun S., and Pantel K. Micrometastatic bone marrow involvement: detection and prognostic significance. Med Oncol 16 (1999) 154-165
28. Muller P., and Schlimok G. Bone marrow micrometastases of epithelial tumors: detection and clinical relevance. J Cancer Res Clin Oncol 126 (2000) 607-618
29. Nagrath S., Sequist L.V., Maheswaran S., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450 (2007) 1235-1239
30. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
31. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
32. Hsieh J.S., Lin S.R., Chang M.Y., et al. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Am Surg 71 (2005) 336-343
33. Leon S.A., Shapiro B., Sklaroff D.M., et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37 (1977) 646-650
34. Stroun M., Anker P., Maurice P., et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46 (1989) 318-322
35. Bremnes R.M., Sirera R., and Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?. Lung Cancer 49 (2005) 1-12
36. Stroun M., Lyautey J., Lederrey C., et al. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313 (2001) 139-142
37. Fleischhacker M., and Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta 1775 (2007) 181-232
38. Zehentner B.K. Detection of disseminated tumor cells: strategies and diagnostic implications. Expert Rev Mol Diagn 2 (2002) 41-48
39. Silva J.M., Rodriguez R., Garcia J.M., et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 50 (2002) 530-534
40. Anker P., Mulcahy H., and Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation: time for large scale clinical studies?. Int J Cancer 103 (2003) 149-152
41. Wyld D.K., Selby P., Perren T.J., et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79 (1998) 288-293
42. Solmi R., De Sanctis P., Zucchini C., et al. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR. Int J Oncol 25 (2004) 1049-1056
43. Wu C.H., Lin S.R., Yu F.J., et al. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int J Cancer 119 (2006) 373-379
44. Chen C.C., Chang T.W., Chen F.M., et al. Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array. Oncology 70 (2006) 438-446
45. Wang J.Y., Yeh C.S., Chen Y.F., et al. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. Int J Mol Med 17 (2006) 737-747
46. Yeh C.S., Wang J.Y., Wu C.H., et al. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Int J Oncol 28 (2006) 411-420
47. Sheu C.C., Yu Y.P., Tsai J.R., et al. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer. Int J Cancer 119 (2006) 1419-1426
48. Denis M.G., Lipart C., Leborgne J., et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 74 (1997) 540-544
49. Wharton R.Q., Jonas S.K., Glover C., et al. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 5 (1999) 4158-4163
50. Ito S., Nakanishi H., Hirai T., et al. Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett 183 (2002) 195-203
51. Wang J.Y., Wu C.H., Lu C.Y., et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance in the prediction of postoperative metastasis. World J Surg 30 (2006) 1007-1013
52. Salbe C., Trevisiol C., Ferruzzi E., et al. Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients. Int J Biol Markers 15 (2000) 300-307
53. Hibi K., Robinson C.R., Booker S., et al. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58 (1998) 1405-1407
54. Wang J.Y., Hsieh J.S., Chang M.Y., et al. Molecular detection of the APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. World J Surg 28 (2004) 721-726
55. Lecomte T., Berger A., Zinzindohoué F., et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer 100 (2002) 542-548
56. Flamini E., Mercatali L., Nanni O., et al. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res 12 (2006) 6985-6988
57. Schwarzenbach H., Stoehlmacher J., Pantel K., et al. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann NY Acad Sci 1137 (2008) 190-196
58. Boni L., Cassinotti E., Canziani M., et al. Free circulating DNA as possible tumour marker in colorectal cancer. Surg Oncol 16 Suppl 1 (2007) 29-31
59. Zehentner B.K. Detection of disseminated tumor cells: strategies and diagnostic implications. Expert Rev Mol Diagn 2 (2002) 41-48
60. Wang J.Y., Wu C.H., Lu C.Y., et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance in the prediction of postoperative metastasis. World J Surg 30 (2006) 1007-1013
61. Jonas S., Windeatt S., O-Boateng A., et al. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 39 (1996) 717-721
62. Lledó S.M., Garcia-Granero E., Dasí F., et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis 6 (2004) 236-242
63. Ruud P., Fodstad O., and Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80 (1999) 119-125
64. Wyld D.K., Selby P., Perren T.J., et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79 (1998) 288-293
65. Bustin S.A., Gyselman V.G., Siddiqi S., et al. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients. Int J Surg Investig 2 (2000) 49-57
66. Vlems F.A., Diepstra J.H., Cornelissen I.M., et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. Mol Pathol 55 (2002) 156-163
67. Bessa X., Elizalde J.I., Boix L., et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 120 (2001) 1084-1092
68. Conzelmann M., Linnemann U., and Berger M.R. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?. Int J Colorectal Dis 20 (2005) 137-146
69. Shen C., Hu L., Xia L., et al. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Jpn J Clin Oncol 38 (2008) 770-776
70. Yeh C.S., Wang J.Y., Wu C.H., et al. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Int J Oncol 28 (2006) 411-420
71. Schuster R., Max N., Mann B., et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 108 (2004) 219-227
72. Duffy M.J. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clin Chem 47 (2001) 624-630
73. Wang J.Y., Lu C.Y., Chu K.S., et al. Prognostic significance of per-and post-operative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res 39 (2007) 245-250
74. Wang J.Y., Lin S.R., Wu D.C., et al. Multiple molecular markers as predictors of colorectal cancer in patients with normal peri-operative serum CEA levels. Clin Cancer Res 13 (2007) 2406-2413
75. Uen Y.H., Lu C.Y., Tsai H.L., et al. The persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol 15 (2008) 2120-2128
76. Uen Y.H., Lin S.R., Wu D.C., et al. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg 246 (2007) 1040-1046
77. André T., Sargent D., Tabernero J., et al. Current issues in adjuvant treatment of stage II colon cancer. Ann Surg Oncol 13 (2006) 887-898
78. Koch M., Kienle P., Kastrati D., et al. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer. Int J Cancer 118 (2006) 3072-3077
79. Funaki N.O., Tanaka J., Sugiyama T., et al. Perioperative quantitative analysis of cytokeratin 20 mRNA in peripheral venous blood of patients with colorectal adenocarcinoma. Oncol Rep 7 (2000) 271-276
80. Yamaguchi K., Takagi Y., Aoki S., et al. Significant detection of circulating cancer cells in the blood by reverse transcriptasepolymerase chain reaction during colorectal cancer resection. Ann Surg 232 (2000) 58-65
81. Weitz J., Koch M., Kienle P., et al. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg 232 (2000) 66-72
82. Guller U., Zajac P., Schnider A., et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236 (2002) 768-775
83. O'Sullivan G.C., Collins J.K., Kelly J., et al. Micrometastases: marker of metastatic potential or evidence of residual disease. Gut 40 (1997) 512-515
84. Recchia F., Candeloro G., Necozione S., et al. Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer. Am J Clin Oncol 31 (2008) 323-328
85. Lièvre A., Bachet J.B., Boige V., et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 26 (2008) 374-379
86. Karapetis C.S., Khambata-Ford S., Jonker D.J., et al. K-rasmutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359 (2008) 1757-1765
87. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Available at http://www.nccn.org/index.asp [Date accessed: January 2009]
88. Di Fiore F., Charbonnier F., Lefebure B., et al. Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer. Br J Cancer 99 (2008) 551-552